A longtime shortage of a type of sterile intravenous saline is now resolved, the Food and Drug Administration announced Friday. According to the FDA, sodium chloride 0.9% injection products ...

Our strong second-quarter results were driven by better-than-expected organic revenue growth, gross margin expansion, operating efficiency and cash generation, as well as a stronger-than-expected ...

A shortage of intravenous and injectable saline solutions in the United States has now been resolved, U.S. Food and Drug ...

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

Isolated severe storms were possible from the Brainerd lakes area up to International Falls with the best chance after 3 a.m.

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential ...

Baxter saw its stock price plunge by more than 20% after it lowered its revenue projections for the remainder of this year, ...

Baxter International has voluntarily paused shipments and planned installations of its Novum infusion pump. In April, the FDA reported an underinfusion risk with the company’s Novum IQ large-volume ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

Q2 2025 Earnings Call Transcript July 31, 2025 Baxter International Inc. misses on earnings expectations. Reported EPS is ...